Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2SARS COV-2에 대한 IgM 및 IgG 항체의 검출에 대한 6 개의 상업적 면역 분석의 장기 종단 평가Multicenter Study Published on 2021-06-262022-09-01 Journal: Viruses [Category] MERS, SARS, 진단, 치료기술, 치료제, [키워드] Analysis antibody antibody levels Antigen assays best Characteristics Chemiluminescent assay chemiluminescent immunoassay CLIA clinical form CMIA concern COVID-19 data interpretation detection disease severity ECLIA ELISA evaluated Follow-up visit follow-up visits healthy humoral Humoral response IgG IgM IgM and IgG immunoassay Increases independent longitudinal Microparticle moderate Patient performed positive post-symptom onset PSO raised remained required sample selection SARS CoV-2 SARS-CoV-2 SARS-COV-2 infection sensitivity Seroconversion Serological assay serological assays serology Seropositivity serum sample serum samples severity Severity of disease significantly specificity the disease were used [DOI] 10.3390/v13071244 PMC 바로가기 [Article Type] Multicenter Study
Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests정량적 이중 ELISA 검사에서 핵단백질 및 스파이크 단백질 단편 2를 사용하여 SARS-CoV-2 진단 개선Original Paper Published on 2021-06-082022-09-11 Journal: Epidemiology and Infection [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] (Abbott) Abbott antibody antibody levels Antibody test Antibody testing antibody tests causative agent Combination Community complement coronavirus coronavirus disease COVID-19 COVID-19 diagnosis detect determine develop diagnosing Diagnosis diagnosis of SARS-CoV-2 diagnostic diagnostic test disease ELISA ELISA test ELISAs enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays epidemiological greater herd immunity Immunity immunogenic Improved individual Infection Novel coronavirus nucleocapsid nucleocapsid protein pandemic Patient positive produced Protein Quantitative respiratory response SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 proteins SARS-CoV-2 viral serum Severe acute respiratory syndrome severe disease specific antibodies specific antibody Spike protein Spread subunit Surveillance Viral proteins virus virus spread were used [DOI] 10.1017/S0950268821001308 PMC 바로가기 [Article Type] Original Paper
Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infectionCOVID-19 감염에서 회복된 후 항-SARS-CoV-2 항체 역학 및 임상 특징의 종단적 평가Article Published on 2021-06-012022-09-11 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute phase acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody Anti-spike antibody Antibody dynamics antibody kinetics antibody level antibody levels Antibody titers association Asymptomatic body mass body mass index Chain Reaction clinical feature Clinical features collected concerning convalescence coronavirus correlated COVID-19 infection detectable disease severity dysfunction Fever follow-up period Frequency Gustatory immune response Immunity Immunoglobulin long-lasting Longevity longitudinal longitudinal analysis Longitudinal assessment material olfactory participant Participants patients polymerase chain polymerase chain reaction post-COVID syndrome qRT-PCR Quantitative questionnaire Receptor binding domain reported symptoms respiratory SARS-CoV-2 SARS-COV-2 infection Serological immune response. serological response serum sample serum samples severe acute respiratory syndrome Coronavirus severity smoking smoking status subunit suffered Symptom syndrome the disease were assessed [DOI] 10.1016/j.ijid.2021.04.080 PMC 바로가기 [Article Type] Article
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study투석 환자에서 mRNA 또는 벡터 기반 SARS-CoV-2 백신 1차 접종의 면역원성: 다기관 전향적 관찰 파일럿 연구Observational Study Published on 2021-05-292022-09-10 Journal: Journal of Nephrology [Category] MERS, SARS, 임상, 치료법, [키워드] Abstract ACE2 receptor binding inhibition capacity antibody antibody levels BNT162b2 ChAdOx1 controls COVID-19 COVID-19 infection defined demonstrated dialysis dose first dose first vaccination healthy Hemodialysis IgG IgG levels immunogenicity median mRNA mRNA- or vector-based SARS-CoV-2 vaccination multicenter nucleocapsid Patient patients Peritoneal dialysis pilot study plasma quartile Responder responders Result risk SARS-CoV-2 spike SARS-CoV-2 vaccination spike IgG tested Vaccine [DOI] 10.1007/s40620-021-01076-0 PMC 바로가기 [Article Type] Observational Study
Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adultsSARS-CoV-2 감염 6개월 후 소아의 혈청 IgG 수치 및 성인과의 비교Original Article Published on 2021-05-222022-09-11 Journal: European journal of pediatrics [Category] MERS, SARS, 진단, 치료기술, [키워드] affected age anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgM antibody antibody levels Antibody Response Antibody responses blood test blood tests both group both groups caution children clinical manifestations collected correlation COVID-19 Ct value cycle threshold declined detect Diagnosis enrolled Evidence General population highlight IgG IgG level IgG titer IgG titers Immunity implication Infection lack no significant difference no significant differences occurred outbreak parent parents pediatric performed PROTECT Quantitative real-time RT-PCR recent Reinfection SARS-CoV-2 SARS-COV-2 infection serological test Serological tests Sex significantly Surveillance Swab the antibody response Therapies Vaccinations virus waned [DOI] 10.1007/s00431-021-04124-w PMC 바로가기 [Article Type] Original Article
Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay정량적 상업 분석을 사용한 SARS-CoV-2 혈청학에 대한 건조 혈반 검사 평가Article Published on 2021-05-222022-09-01 Journal: Viruses [Category] SARS, 진단, [키워드] anti-S antibody antibody level antibody levels Antibody Response Antibody responses Blood Characteristics Concordance correlated COVID-19 DBS sample DBS samples Diagnosis dried blood spot Dried blood spots elution extrapolation facilitate False negative false negatives feasible Immunity Infection investigated Laboratory testing occur PCR-confirmed COVID-19 patient PCR-confirmed COVID-19 patients phlebotomy plasma plasma antibody Quantitative reduced Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody serologic testing serology spike glycoprotein spot tested Testing vaccination virus viruses widespread [DOI] 10.3390/v13060962 PMC 바로가기 [Article Type] Article
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients회복기 혈장에서 높은 수준의 일반적인 감기 코로나바이러스 항체는 COVID-19 환자의 생존율 향상과 관련이 있습니다Clinical Trial Published on 2021-04-282022-08-13 Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단, [키워드] Administered age Anderson Cancer Center anti-HCoV-HKU1 spike IgG anti-HCoV-OC43 anti-HCoV-OC43 spike IgG anti-SARS-CoV-2 antibodies antibody antibody levels Antigen antigens association Bayesian Bayesian exponential survival time regression model Cancer patients CCP CCP administration Cold common common cold convalescent plasma coronavirus coronavirus antibodies coronavirus strains COVID-19 COVID-19 convalescent plasma COVID-19 infection COVID-19-related complications died domain early stage effective Factor female HCoV-HKU1 HCoV-OC43 HKU1 Hospitalized identify IgG antibodies Improved Level MD Anderson Cancer Center median age moderate moderate to severe monoclonal antibody non-SARS-CoV-2-specific antibodies OC43 Other other coronaviruses outcomes Patient PBE PBEs posterior probability prognostic variable prognostic variables quantified Regression model Result Safe SARS-CoV-2 SARS-CoV-2-specific antibody Severe COVID-19 Infection Sex specific antibodies specific antibody spike IgG survival survival time the disease therapeutic target [DOI] 10.3389/fimmu.2021.675679 PMC 바로가기 [Article Type] Clinical Trial
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection새로운 ELISA 프로토콜은 기존 SARS-CoV-2 반응성 항체를 풍토성 코로나바이러스 면역 및 연령과 연결하고 다중 매개변수 감지를 통해 급성 COVID-19의 향상된 혈청학적 식별을 나타냅니다.Immunology Published on 2021-04-092022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] Abbott Abbott test acute COVID-19 added age antibodies antibody Antibody detection antibody levels approved assays binding domain buffer circulating coated coronavirus COVID-19 COVID-19 pandemic detection Dilution disease disease status Economy ELISA ELISA protocol Endemic EUA HIV Hospitalized identification IgA IgA antibodies IgA antibody IgA level IgA levels IgG IgM Immunity immunoassay impacted implication Improved infected individuals information life magnitude measurement Microparticle novel nuance nuances nucleocapsid (N) nucleocapsid protein optical densities optical density platform pre-existing immunity RBD reactive reagents receptor binding domain (RBD) reported SARS-CoV-2 SARS-CoV-2 IgM SARS-CoV-2 infected individual SARS-COV-2 infection SARS-CoV-2 pathogenesis SARS-CoV-2 RBD SARS-CoV-2 receptor SARS-CoV-2 specific antibodies SARS-CoV-2 specific antibody sensitive serologic serology serology test significantly lower SLE specific IgM standard curve Strains subject subjects Symptoms utility Viral protein Viral proteins virus transmission [DOI] 10.3389/fimmu.2021.614676 PMC 바로가기 [Article Type] Immunology
Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donorsCOVID-19 회복기 혈장 기증자에서 SARS-CoV-2 중화 항체의 존재 및 단기 지속성Article Published on 2021-04-012022-09-11 Journal: Transfusion [Category] MERS, SARS, 진단, 치료기술, [키워드] Analysis antibody antibody levels Antibody Response Antibody titers Antigen approved best Blood blood component preparations. CCP Children's Hospital collected convalescent plasma correlation COVID-19 COVID-19 patients criteria detectable Donor donors drug evaluate evaluated FDA FFP transfusion focus food FRNT implementation individual less Live virus majority miss a neutralization neutralization test Neutralizing activity Neutralizing antibody titer neutralizing antibody titers Patient persistence Presence protocol quantitative assay Quantitative assays reduction Regulatory Regulatory and QA robust SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 antigen SARS-CoV-2 neutralizing antibody SARS-CoV-2 nucleoprotein sustained therapeutic therapeutic use titer Treatment treatment of COVID-19 Variability [DOI] 10.1111/trf.16261 PMC 바로가기 [Article Type] Article
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials단회 투여 및 ChAdOx1 nCoV-19(AZD1222) 백신의 면역원성 및 효능에 대한 추가 투여 시간의 영향: 4건의 무작위 시험에 대한 통합 분석Meta-Analysis Published on 2021-03-062022-09-10 Journal: Lancet (London, England) [Category] MERS, SARS, 임상, [키워드] 1:1 95% CI addition administration Ageusia All participants Analysis Anosmia antibody antibody levels Antibody Response Antibody responses approved assigned AstraZeneca AZD1222 baseline binding antibody booster dose booster doses Brazil category ChAdOx1 ChAdOx1 nCoV-19 Clinical research Coalition control group control vaccine cough COV005 COVID-19 COVID-19 disease COVID-19-related death Cutoff death defined described dose doses double-blind Efficacy Emergency use Endpoint Evidence evidence of exclusion exploratory Exploratory analyses Exploratory analysis Fever finding first dose FIVE Follow-up for inclusion foundation funding geometric mean geometric mean ratio GMR had no Hospital admission immunoassay immunogenicity immunogenicity data independent indicated individual Infection initial Innovation interim analysis ISRCTN89951424 less lower dose Medicine Medicines Medicines and Healthcare products Regulatory Agency Melinda Gate Melinda Gates N protein NAAT NAAT-positive swab network neutralisation NIHR no evidence of nucleic acid nucleic acid amplification nucleic acid amplification test observation offered Older outcomes Oxford pandemic participant phase 2/3 phase 3 study positive swab primary analysis primary endpoint Primary outcome prime-boost interval priming PROTECT pseudovirus randomised controlled Randomised trial Randomly receive receiving recruited regimen Registered regulatory authority response Safety saline placebo SARS-COV-2 infection SARS-CoV-2 N protein second dose secondary Serious Adverse Events seronegative Seven Shortness of breath single-blind Single-dose South South Africa Standard dose subset supported Swab swabs Symptom symptomatic COVID-19 disease symptomatic infection Telle the primary endpoint the timing the vaccine Trial vaccination Vaccine vaccine efficacy Valley Viral Viral particles [DOI] 10.1016/S0140-6736(21)00432-3 PMC 바로가기 [Article Type] Meta-Analysis